Researcher.Life Logo

Cardio-Oncology : Impact Factor & More

eISSN: 2057-3804pISSN: 2057-3804
JournalOpen Access

Key Metrics

CiteScore
2.3
SNIP
0.88
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cardio-Oncology

Cardio-Oncology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2090 | USD 2490 | GBP 1690
Publication Time7
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2015
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 7
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Cardio-Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cardio-Oncology

Neck adiposity on standard oncologic CT predicts radiation-induced carotid disease in oropharyngeal cancer.
  • 25 Apr 2026
  • Cardio-oncology (London, England)
Anticoagulation challenges in cancer patients: prevention, detection, and treatment strategies.
  • 23 Apr 2026
  • Cardio-oncology (London, England)
Sacubitril/valsartan for the prevention of cancer therapy-related cardiac dysfunction: a systematic review and meta-analysis.
  • 22 Apr 2026
  • Cardio-oncology (London, England)
The state of cardio-oncology in Oman: awareness, practices, and training needs among healthcare providers: a survey-based study.
  • 22 Apr 2026
  • Cardio-oncology (London, England)
Entrectinib results in ventricular tachycardia and Brugada phenocopy through inhibition of sodium current.
  • 21 Apr 2026
  • Cardio-oncology (London, England)
Evaluating the impact of Lutetium-177 therapy on bioprosthetic heart valves in carcinoid heart disease.
  • 20 Apr 2026
  • Cardio-oncology (London, England)
Neck adiposity on standard oncologic CT predicts radiation-induced carotid disease in oropharyngeal cancer.
  • 25 Apr 2026
  • Cardio-oncology (London, England)
Anticoagulation challenges in cancer patients: prevention, detection, and treatment strategies.
  • 23 Apr 2026
  • Cardio-oncology (London, England)
Sacubitril/valsartan for the prevention of cancer therapy-related cardiac dysfunction: a systematic review and meta-analysis.
  • 22 Apr 2026
  • Cardio-oncology (London, England)
The state of cardio-oncology in Oman: awareness, practices, and training needs among healthcare providers: a survey-based study.
  • 22 Apr 2026
  • Cardio-oncology (London, England)
Entrectinib results in ventricular tachycardia and Brugada phenocopy through inhibition of sodium current.
  • 21 Apr 2026
  • Cardio-oncology (London, England)
Evaluating the impact of Lutetium-177 therapy on bioprosthetic heart valves in carcinoid heart disease.
  • 20 Apr 2026
  • Cardio-oncology (London, England)

FAQs on Cardio-Oncology